Accenture (ACN) Stock Rebounds Amid Analyst Downgrades: Is It Time to Buy?

Key Takeaways

• ACN shares advanced 1.65% Friday, finishing at $170.28 and breaking a five-session decline, yet trading 46% under its 52-week peak of $317.31
• Vontobel Holding increased its ACN position by 36.8% during Q4, purchasing 43,637 additional shares valued at approximately $43.5 million
• Chief Executive Atsushi Egawa divested 4,872 shares at $177.14 on April 30 through a predetermined Rule 10b5-1 trading arrangement
• Truist shifted its stance on ACN from Buy to Hold while reducing the price objective from $260 down to $210; multiple firms followed suit with target reductions
• The consulting giant exceeded Q3 profit expectations, delivering EPS of $2.93 against the $2.84 forecast, with revenues reaching $18.04 billion

Shares of Accenture (ACN) climbed 1.65% during Friday’s trading session, settling at $170.28 and breaking a five-consecutive-day decline. The wider market also posted gains, with the S&P 500 advancing 0.50% while the Dow Jones increased 0.70%.

Accenture plc, ACN

While Friday’s uptick provided temporary relief, ACN shares remain 46% beneath their 52-week peak of $317.31. This significant differential reflects the shift in market sentiment toward the stock over recent months.

Friday’s trading volume registered at 4.0 million shares, falling short of the 50-day average volume of 5.4 million, indicating the upward movement lacked strong institutional backing.

ACN began Friday’s session at $169.95. The stock has established a 12-month floor of $155.82 and maintains a market capitalization approaching $113 billion. Technical indicators show the 50-day moving average positioned at $181.79, with the 200-day moving average at $221.83 — both substantially above current price levels.

Institutional Accumulation Contrasts with Executive Divestment

Vontobel Holding expanded its ACN stake by 36.8% throughout Q4, acquiring 43,637 additional shares. The investment firm currently maintains 162,315 shares with an estimated value of $43.5 million.

Several major institutional players have also modified their holdings. Vanguard purchased 854,361 shares during Q4, elevating its total position beyond 66 million shares. Massachusetts Financial Services expanded its stake by 5.4%, adding 546,198 shares to its portfolio. Institutional ownership of ACN currently stands at 75.14%.

Meanwhile, Chief Executive Atsushi Egawa executed a sale of 4,872 shares on April 30 at an average transaction price of $177.14, generating approximately $863,000 in proceeds. This divestment occurred under a pre-established Rule 10b5-1 trading plan, leaving Egawa with 12,802 remaining shares.

The transaction decreased his direct ownership by 27.57%, a notable reduction despite the pre-planned nature of the sale.

Analyst Community Reassesses Valuation Expectations

Wall Street analysts have recently recalibrated their outlook on ACN. Truist made the most significant adjustment, downgrading the stock from Buy to Hold while slashing its price objective from $260 to $210 on June 1.

Wells Fargo reduced its target from $275 to $248 while preserving an Overweight rating. Morgan Stanley decreased its objective from $320 to $240, also keeping an Overweight stance. Royal Bank of Canada adjusted downward from $295 to $253 with an Outperform designation. BMO Capital Markets lowered its target from $300 to $230 alongside a Market Perform rating.

Notwithstanding these reductions, the consensus recommendation from 27 analysts maintains a Moderate Buy rating, with an average price target of $259.89 — suggesting approximately 53% upside from current levels.

Strong Quarterly Results and Consistent Dividend

ACN released its quarterly financial results on March 20, reporting earnings per share of $2.93, surpassing the analyst consensus of $2.84. The company generated $18.04 billion in revenue, exceeding the $17.80 billion projection, representing a 7.8% year-over-year increase.

The corporation distributed a quarterly dividend of $1.63 per share on May 15. This translates to an annualized dividend of $6.52, yielding 3.8% based on the current share price. The dividend payout ratio is calculated at 53.40%.

Analyst projections currently anticipate full-year earnings per share of $13.87 for the fiscal year.

The post Accenture (ACN) Stock Rebounds Amid Analyst Downgrades: Is It Time to Buy? appeared first on Blockonomi.